Boston-based Dana-Farber Cancer Institute recently made its first official pitch to Massachusetts regulators about its $1.68 billion proposal to establish a standalone cancer hospital in partnership with Beth Israel Deaconess Medical Center, The Boston Globe reported Jan. 8. 

Charleston, S.C.-based MUSC Hollings Cancer Center has named William Hawkins, MD, as its inaugural deputy director, according to a Jan. 3 news release.

Mayo Clinic is launching a $9 million expansion and renovation to its New Prague cancer center beginning in 2024.

Most private and federal health insurance programs require prior authorization for certain treatments in order to reduce spending and avoid unnecessary care; however, the process may increasingly prevent patients from receiving the right care when they need it, The Lund Report reported Jan. 2.

Seattle-based Fred Hutchinson Cancer Center is facing nine lawsuits after a cyberattack leaked clinical data in November.

Atlanta-based Piedmont health system has announced the formation of a program to improve access for cancer patients to "promising" cell, gene and immunotherapies as well as detection strategies, according to a Jan. 2 news release shared with Becker's.

The death of a study participant has prompted the FDA to place a clinical hold on an Iovance Biotherapeutics trial, the company said Dec. 22.

Walmart has partnered with RadNet to offer its first pilot mammogram program in a store in Milford, Del.

A recent Becker's poll found treatment options were voted the area most in need of change in cancer care.

Here are 123 cancer centers opening, expanding or affiliating:

Here are 107 oncologists starting new roles:

The Northwestern Medicine St. George Cancer Institute opened its expanded services thanks to a $51 million gift, the Chicago Tribune reported Dec. 20.

Morphine is widely considered the "gold-standard treatment" for pain during cancer care, but a new study found the drug was not superior to other opiates. 

The U.S. Defense Department has awarded a $3.2 million research grant to fund "unconventional" cancer research at the University of Southern California in Los Angeles. The grant will form the Convergent Science Cancer Consortium, which will bring together experts from multiple disciplines including biology, engineering, mathematics and computer science to tackle new approaches to cancer research.

New York state is calling for proposals for developers to build a 200,000-square-foot cell and gene therapy hub.

Here are the top 25 cancer stories Becker's reported on in 2023:

Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.

Syracuse, N.Y.-based St. Joseph's Health is partnering with Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., to bring more oncology services to local residents.

Indianapolis-based Community Health Network is adding two cancer treatments to its cancer center thanks to a partnership with Houston-based MD Anderson Cancer Center, Inside Indiana Business reported Dec. 14.

UChicago Medicine has received a $20 million gift to support the development of a cancer care and research facility that's slated to open in 2027.